---
title: "基地錦標集團委任陳鉅銘為執行董事兼董事會聯席主席"
description: "智通財經 APP 訊，基地錦標集團公佈，劉頌豪先生已辭任該公司執行董事、行政總裁及法定代表，自 2025 年 9 月 10 日起生效。同日起，公司的公司秘書陳鉅銘先生已獲委任為執行董事兼董事會聯席主席。"
type: "news"
locale: "zh-HK"
url: "https://longbridge.com/zh-HK/news/256918781.md"
published_at: "2025-09-11T11:53:05.000Z"
---

# 基地錦標集團委任陳鉅銘為執行董事兼董事會聯席主席

> 智通財經 APP 訊，基地錦標集團公佈，劉頌豪先生已辭任該公司執行董事、行政總裁及法定代表，自 2025 年 9 月 10 日起生效。同日起，公司的公司秘書陳鉅銘先生已獲委任為執行董事兼董事會聯席主席。

智通財經 APP 訊，基地錦標集團 (08460) 公佈，劉頌豪先生已辭任該公司執行董事、行政總裁及法定代表，自 2025 年 9 月 10 日起生效。

同日起，公司的公司秘書陳鉅銘先生已獲委任為執行董事兼董事會聯席主席。

### Related Stocks

- [08460.HK - 基地錦標集團](https://longbridge.com/zh-HK/quote/08460.HK.md)

## Related News & Research

| Title | Description | URL |
|-------|-------------|-----|
| Basetrophy Group Holdings Reports Over 200% Monthly Sales Increase in January 2026 | Basetrophy Group Holdings Ltd. reported a significant sales increase of over 200% in January 2026, with sales reaching a | [Link](https://longbridge.com/zh-HK/news/274417300.md) |
| 15:34 ETNational Assistance League Appoints Judy Zulfiqar as Executive Director | National Assistance League has appointed Judy Zulfiqar as its new Executive Director. With over 20 years of experience i | [Link](https://longbridge.com/zh-HK/news/275804629.md) |
| CSPC Pharmaceutical says ropivacaine long-acting injection approved for clinical trials in China | CSPC Pharmaceutical says ropivacaine long-acting injection approved for clinical trials in China | [Link](https://longbridge.com/zh-HK/news/276051793.md) |
| CSPC Pharmaceutical Receives Regulatory Nods to Begin Drug Trials | CSPC Pharmaceutical Receives Regulatory Nods to Begin Drug Trials | [Link](https://longbridge.com/zh-HK/news/276035104.md) |
| Nomura Adjusts CSPC Pharmaceutical Group's Price Target to HK$12.04 From HK$9.11, Keeps at Buy | Nomura Adjusts CSPC Pharmaceutical Group's Price Target to HK$12.04 From HK$9.11, Keeps at Buy | [Link](https://longbridge.com/zh-HK/news/276056763.md) |

---

> **免責聲明**：本文內容僅供參考，不構成任何投資建議。